Oncology Peer Review On-The-Go: COVID-19, Cancer, and the Potential of mRNA Vaccines

March 30, 2021
Matthew Fowler

Mehmet Sitki Copur, MD, discussed his article in the Journal ONCOLOGY® focusing on COVID-19, messenger RNA vaccines, and the excitement surrounding its integration into the future of cancer treatment.

This episode of the “Oncology Peer Review On-The-Go” podcast centers around an article publishing in the April issue of the Journal ONCOLOGY®, titled “Messenger RNA Vaccines-Beckoning of a New Era in Cancer Immunotherapy.” The article touches on the recent development of mRNA vaccines approved to combat COVID-19 and how this offers optimism for the future of mRNA to treat patients with cancer.

The author, Mehmet Sitki Copur, MD, of the University of Nebraska Medical Center, broke down the basics of mRNA, its history, challenges, and potential opportunities around this relatively new class of vaccine.

Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.